ORIFARM PI A/S: Financial statements 2015
CVR: 27347177
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -27,000 and a net result of DKK 25,311,000 compared with DKK 18,740,000 the year before. Equity in the 2015 report amounted to DKK 206,221,000. The solvency ratio was 62.3%.
- Gross Profit
- DKK -27,000
- Profit/Loss
- DKK 25,311,000
- Equity
- DKK 206,221,000
- Total Assets
- DKK 331,241,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -27K | 25.3M | 206.2M | - |
| 2014 | - | -30K | 18.7M | 59M | - |
| 2013 | - | -30K | 18.5M | 42.6M | - |
| 2012 | - | -46K | 17.6M | 25.6M | - |
Official annual report
How creditworthy is ORIFARM PI A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
ORIFARM PI A/S has published its annual report for 2014. Gross profit came to DKK -30,000, and the net result was DKK 18,740,000.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.